Table 1. Patient characteristics.
| Variable | Value |
|---|---|
| Age (yr), median (range) | 59 (30-88) |
| Modality | |
| ICBT | 42 |
| ISBT | 15 |
| Histology | |
| Adenocarcinoma | 2 |
| Squamous cell carcinoma | 55 |
| TNM stage | |
| T1b | 2 |
| T2a | 3 |
| T2b | 17 |
| T3a | 3 |
| T3b | 31 |
| T4a | 1 |
| N0 | 39 |
| N1 | 18 |
| M1* | 1 |
| EBRT (Gy), median (range) | |
| Whole pelvic radiotherapy | 30 (0-50.4) |
| Center shield | 20 (0-40) |
| Brachytherapy, median (range) | |
| ICBT (Gy) | 30 (16.5-47) |
| (fraction) | 4 (2-5) |
| ISBT (Gy) | 30 (30-54) |
| (fraction) | 5 (4-9) |
External radiotherapy is performed by 1.8 or 2 Gy/fr.
EBRT, external radiotherapy; ICBT, intracavitary brachytherapy; ISBT, interstitial brachytherapy; M, metastasis; N, node; T, tumor.
*Para-aortic lymph node metastasis.